Company / Current Assets per Share
Bioventus Inc. Current Assets per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$4.36
FY2025
5-year range
$4.36 / $5.99
FY2021-FY2025
Trend
-3.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has declined for 3 consecutive years, from $5.99 in FY2022 to $4.36 in FY2025.
Based on SEC 10-K filings.
4.36 in FY2025 with a 3-year CAGR of -10.1%.
Declined from $5.89 to $4.36 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -10.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Bioventus Inc.'s current assets per share has declined for 3 consecutive years.
- In FY2025, current assets per share decreased 3.0% year-over-year.
- Peak current assets per share was recorded in FY2022.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.36 | -3.0% |
| FY2024 | $4.49 | -23.8% |
| FY2023 | $5.89 | -1.7% |
| FY2022 | $5.99 | +3.6% |
| FY2021 | $5.79 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026